Use Of Green Porphyrinsto Treat Neovasculature In The Eyes
Patent
·
OSTI ID:879252
- Vancouver, CA
- Boston, MA
- Arlington, MA
- Luebeck, DE
Photodynamic therapy of conditions of the eye characterized by unwanted neovasculature, such as age-related macular degeneration, is effective using green porphyrins as photoactive agents, preferably as liposomal compositions.
- Research Organization:
- Massachusetts General Hospital
- DOE Contract Number:
- FG02-91ER61228
- Assignee:
- The General Hospital Corporation (Boston, MA); Quadra Logic Technologies, Inc. (Vancouver, B.C., CA); Massachuesetts Eye & Ear Infirmary (Boston, MA)
- Patent Number(s):
- US 5798349
- Application Number:
- 08/390591
- OSTI ID:
- 879252
- Country of Publication:
- United States
- Language:
- English
Photodynamic Therapy of Experimental Choroidal Melanoma Using Lipoprotein-delivered Benzoporphyrin
|
journal | January 1994 |
Efficient syntheses of new classes of regiochemically pure benzoporphyrin derivatives
|
journal | December 1993 |
Similar Records
Angiographic Method Using Green Porphyrinew In Primmate Eyes
Effect of irradiation on neovascularization in rat skinfold chambers: Implications for clinical trials of low-dose radiotherapy for wet-type age-related macular degeneration
Conservation and diversity in the secondary forward photodynamics of red/green cyanobacteriochromes
Patent
·
Tue Jan 13 00:00:00 EST 1998
·
OSTI ID:879252
Effect of irradiation on neovascularization in rat skinfold chambers: Implications for clinical trials of low-dose radiotherapy for wet-type age-related macular degeneration
Journal Article
·
Wed Dec 01 00:00:00 EST 2004
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:879252
Conservation and diversity in the secondary forward photodynamics of red/green cyanobacteriochromes
Journal Article
·
Tue Sep 03 00:00:00 EDT 2019
· Photochemical & Photobiological Sciences
·
OSTI ID:879252
+4 more